2. Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol 2013;121:654-73.
3. Nivedhana AP, Jalakandan B, Gunaseelan S. Effect of prophylactic tranexamic acid on blood conservation in Indian women undergoing abdominal hysterectomy. Int J Reprod Contracept Obstet Gynecol 2018;7:3538-46.
4. Hansen CT, Møller C, Daugbjerg S, Utzon J, Kehlet H, Ottesen B. Establishment of a national Danish hysterectomy database: preliminary report on the first 13,425 hysterectomies. Acta Obstet Gynecol Scand 2008;87:546-57.
5. Topsoee MF, Bergholt T, Ravn P, Schouenborg L, Moeller C, Ottesen B, et al. Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. Am J Obstet Gynecol 2016;215:72.e1-8.
6. Koh MB, Hunt BJ. The management of perioperative bleeding. Blood Rev 2003;17:179-85.
9. Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999;57:1005-32.
11. Singh D, Bindal J. The effect of prophylactic use of intravenous tranexamic acid in hysterectomy of benign diseases. Int J Clin Obstet Gynaecol 2020;4:93-7.
12. Bhutani S, Malik R, Duhan N. Role of intravenous tranexamic acid (TXA) in reducing perioperative blood loss in hysterectomy for benign gynecological conditions. Authorea 2020 Sep 11 [Epub].
https://doi.org/10.22541/au.159986276.65428056
.
14. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated march 2011) [Internet]. London: Cochrane; c2011. [cited 2022 Apr 2]. Available from:
www.handbook.cochrane.org
.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
17. Dickersin K, Berlin JA. Meta-analysis: state-of-the-science. Epidemiol Rev 1992;14:154-76.
20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
22. Abu-Zaid A, Altowairqi AK, Dissanayaka T, Oganesyan A, Bhagavathul AS, Alhabeeb H, et al. A systematic review and dose-response meta-analysis on the efficacy of dapagliflozin in patients with type 1 diabetes mellitus. Pharmacol Res 2021;165:105456.
24. Traylor J, Runge M, Friedman J, Nixon KE, Tsai SC, Chaudhari A, et al. Intravenous tranexamic acid prior to hysterectomy for reduction of intraoperative blood loss: a randomized placebo-controlled trial. J Minim Invasive Gynecol 2020;27:S5.
27. Thompson JD, Birch HW. Indications of hysterectomy. Clin Obstet Gynecol 1981;24:1245-58.
28. Discepola F, Valenti DA, Reinhold C, Tulandi T. Analysis of arterial blood vessels surrounding the myoma: relevance to myomectomy. Obstet Gynecol 2007;110:1301-3.
30. Dockeray CJ, Sheppard BL, Daly L, Bonnar J. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur J Obstet Gynecol Reprod Biol 1987;24:309-18.
31. Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol 1994;171:178-83.
32. Levy JH, Tanaka KA. Management of surgical hemostasis: systemic agents. Vascular 2008;16(Suppl 1):S14-21.
33. Sileshi B, Achneck HE, Lawson JH. Management of surgical hemostasis: topical agents. Vascular 2008;16(Suppl 1):S22-8.
34. Fraser IS, Porte RJ, Kouides PA, Lukes AS. A benefit-risk review of systemic haemostatic agents: part 1: in major surgery. Drug Saf 2008;31:217-30.
35. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985;29:236-61.
36. Bellos I, Pergialiotis V. Tranexamic acid for the prevention of postpartum hemorrhage in women undergoing cesarean delivery: an updated meta-analysis. Am J Obstet Gynecol 2022;226:510-23e22.
39. Hu M, Liu ZB, Bi G. Efficacy and safety of tranexamic acid in orthopaedic trauma surgery: a meta-analysis. Eur Rev Med Pharmacol Sci 2019;23:11025-31.
41. Ma QM, Han GS, Li BW, Li XJ, Jiang T. Effectiveness and safety of the use of antifibrinolytic agents in total-knee arthroplasty: a meta-analysis. Medicine (Baltimore) 2020;99:e20214.
42. Murji A, Lam M, Allen B, Richard L, Shariff SZ, Austin PC, et al. Risks of preoperative anemia in women undergoing elective hysterectomy and myomectomy. Am J Obstet Gynecol 2019;221:629e1-629.e18.
43. Rock WA Jr, Meeks GR. Managing anemia and blood loss in elective gynecologic surgery patients. J Reprod Med 2001;46:507-14.
44. Rawn J. The silent risks of blood transfusion. Curr Opin Anaesthesiol 2008;21:664-8.
45. Jain SB, Shikha . Decline in blood loss with use of tranexamic acid in cases of hysterectomy: a retrospective observational study in a teaching hospital of central India. IJOGR 2021;8:26-30.
48. Teoh WY, Tan TG, Ng KT, Ong KX, Chan XL, Hung Tsan SE, et al. Prophylactic topical tranexamic acid versus placebo in surgical patients: a systematic review and meta-analysis*. Ann Surg 2021;273:676-83.
49. Hafidh B, Latifah HM, Gari A, Alshahrani MS, AlSghan R, Alkhamis WH, et al. Vasopressin to control blood loss during hysterectomy: a systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol 2022;29:355-694e2.